Lantern Pharma Inc. at Diamond Equity Research Emerging Growth Invitational (Virtual) Transcript
Welcome, everyone, to the Diamond Equity Research conference. With me, I have our next presenter, Panna Sharma, the Chief Executive Officer of Lantern Pharma -- Lantern Technologies (sic) [Lantern Pharma]. And Panna, I'll pass the mic over to you to present.
Hunter, thanks a lot. I appreciate it. And thanks everyone for taking time today to listen to our story. Lantern Pharma is a publicly traded company. We trade on the NASDAQ under the symbol LTRN, and we will be making forward-looking statements today that we may or may not update and are obviously governed by the safe harbor statements.
So I'd like to go ahead and give everyone who's new to the story, a quick overview of what would we do, talk a little bit about our platform that's very unique, our drug portfolio that we're developing and some of the milestones that we will be hitting over the next this quarter and, of course, next year.
I think there's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
